IGHG3 and malaria: However, IgG3 anti ICB2-5 levels were very low (P < 0.05) in individuals who have had malaria in the last 90 days corroborating the idea of poor immunogenicity of Block 2 and requirement of consecutive boosting for variant-specific humoral response (Figure 2(b)).